Global Institute Of Stem Cell Therapy And Research

Archives

Author's Posts

Hi Dr. Anand S. Srivastava,
Greetings from Journal of Stem Cell Research

Journal of Stem Cell Research is successfully publishing quality open access articles with the support from scientists like you. We are aware of your reputation for quality of research and trustworthiness in the field of “Stem Cell Research” and that is why you have been inviting to join as an Editorial Board Member of our Journal of Stem Cell Research.

Please send us your updated CV, biography, research interest and recent passport size photo. 

Feel free to contact us for further assistance. We are ready to serve you.
We look forward for a long lasting scientific relationship with you.

Sincerely,
Rapture D
editor.jscr@opastjournals.com

Managing Editor

Overland Park, KS
US

-->

Liver Cirrhosis Treatment at GIOSTAR – Patient Testimonial

 

 

In April 2016, 55 years old, Mr. Ashwinbhai Soni, suffering with liver cirrhosis arrived at the GIOSTAR after quite sufferings and very concerned about his professional as well as personal life. His viral load was very high and liver enzymes were as well elevated beyond the limits, due to which his doctor suggested him of no other option; but a liver transplant. Read how Mr. Ashwinbhai Soni has undergone stem cell therapy with us and how is he feeling currently.

Hi my name is Ashwinbhai Soni and I am currently working with GV. Since last 4-5 years I had been regularly hospitalized for my weakness, abdominal pain, passing of blood through stool problems. Doctors had initially concluded a liver problem, but the severity of the issue was not noticed till the time, I consulted a gastroenterologist. He consulted me well and check for my personal, professional as well as family history. As per his suggestions, I underwent two-three diagnostic tests; which ultimately concluded a severe liver disease, named liver cirrhosis.

After that I had to be admitted 5-6 times in a hospital every year; for blood transfusions. I have even had blood vomits twice or thrice last year, I used to feel lot of weakness and my friends and family suggested me to take complete rest, considering severity of my issue. At one point of time, I was so frustrated that I was about to leave my job. I had been undergoing treatment at Sterling hospital with gastroenterologist, who ultimately suggested me liver transplant by analysing my biopsy reports. Luckily, through newspaper, I came to know about stem cells therapy at GIOSTAR and how many people have been benefitted without a surgery.

Doctors and specialists at GIOSTAR are very soft, knowledgeable; who made me understand the entire process, including risks and benefits. I finally decided to give a try; before opting for the liver transplant. I underwent total 4 cycles; although each cycle was just a daytime affair. The procedure was too smooth to my expectations; and I could internally feel the change, in the first sessions itself. However, my gastroenterologist was still suggesting me that a transplant is the better option; and this is not going to work.

After 2nd session, I found that my stamina is slowly increasing, along with my appetite and emotional mood swings. After 3rd sessions, I found out that I can work almost 10-12 hrs a day, whereas initially, I was not being able to continue even for 2 hrs. My appetite has considerably increased and I have started living normal life again. Even to my surprise even my gastroenterologist declared that I need not to undergo any transplant and everything is going on very smoothly. I may undergo additional sessions of stem cells therapy, as per expert’s advice; but for now I am very happy and thankful to all the staff of GIOSTAR; for bringing me back into my life.

Invitation from Journal of Clinical Research and Trial to Submit a Manuscript

Dear Anand S,

Greetings from Clinical Research and Trials (CRT) !

This is a special Request regarding manuscript contribution to our Journal. We will be glad if you can submit your manuscript along with cover letter at clinicaltrials@oatextjournals.com

We would like to inform you regarding our Annual Membership Program. Keeping in view your tremendous contribution to the scientific field, we wish to offer you free membership.

Kindly let us know your opinion in this regard. So, that we will send you more details regarding individual membership and other benefits.

Awaiting for your positive response.

Have a great day

Best Regards
Regina Mathew
Editorial Coordinator
Office Gold, building 3 Chiswick Park
Greater London, W4 5YA
United Kingdom

FDA-Approved Study Uses Adipose Stem Cells for Treatment of Shoulder Injuries

 

Sanford Health is conducting the first clinical trial approved by the FDA to treat injured shoulders using patients’ adipose stem cells.

“A number of studies have demonstrated that fat-derived stem cells have great healing potential by boosting the immune system and helping the natural healing process,” Jason Hurd, MD, a principal investigator of the study and orthopedic surgeon at Sanford Orthopedics & Sports Medicine in Sioux Falls, South Dakota, told Orthopedics Today. “Also, isolation of fat tissue is less invasive than isolation of other pools of stem cells, such as those found in the bone marrow, which might include a more complicated surgical procedure.”

Hurd and Mark Lundeen, MD, the other lead investigator of the study, began the trial in December to determine whether adipose stem cells, extracted from a patient’s abdominal fat, could repair partial thickness tears in the rotator cuff, according to a press release from Sanford Health. Investigators hypothesize that injecting the stem cells into the injured area could activate the patient’s body’s natural healing process, accelerate healing and regenerate tissue.

“Sanford Health physicians and scientists are the first in the country to work with the FDA on a trial using adipose stem cells in rotator cuff tears, which are common,” Kelby Krabbenhoft, president and chief executive officer of Sanford Health, said in the release. “We have been monitoring the potential of these types of stem cells for some time. In Europe, adipose stem cells have been used as a therapy option for damaged tissues and are approved to carry the CE mark, which signifies that a product has been assessed by and meets certain safety, health and environmental protection requirements in the European Union.” ‒ by Monica Jaramillo

Source : https://goo.gl/VLSG84

Make An Enquiry

We are here to help you

WordPress Video Lightbox